Mechanism of action and clinical trial results of Lecanemab (Leqembi® 200 mg, 500 mg for Intravenous Infusion), a novel treatment for Alzheimer’s disease
Released on J-STAGE: May 01, 2024 |
Volume 159
Issue 3
Pages 173-181
Tetsuhiro Niidome, Yukio Ishikawa, Tomoo Ogawa, Masaki Nakagawa, Yosuke Nakamura